Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Roll

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Journal of Opioid Management|April 7, 2012
Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adoptersTyler L Quest, Joseph O Merrill, John Roll, et al.
Journal of Cannabis Research|June 2, 2021
Predictors of cannabis and tobacco co-use in youth: exploring the mediating role of age at first use in the population assessment of tobacco health (PATH) studyCrystal Lederhos Smith, Brittany Rhoades Cooper, Andre Miguel, et al.
Behavioural Pharmacology|February 18, 2016
Self-reported smoking effects and comparative value between cigarettes and high dose e-cigarettes in nicotine-dependent cigarette smokersSterling McPherson, Donelle Howell, Jennifer Lewis, et al.
Rural and Remote Health|March 23, 2017
Use of cell phones and computers for health promotion and tobacco cessation by American Indian college students in MontanaJo Ann W Dotson, Lonnie A Nelson, Sara L Young, et al.
Experimental and Clinical Psychopharmacology|September 22, 2015
An application of analyzing the trajectories of two disorders: A parallel piecewise growth model of substance use and attention-deficit/hyperactivity disorderMary Rose Mamey, Celestina Barbosa-Leiker, Sterling McPherson, et al.
Addiction (Abingdon, England)|August 30, 2014
A 'missing not at random' (MNAR) and 'missing at random' (MAR) growth model comparison with a buprenorphine/naloxone clinical trialSterling McPherson, Celestina Barbosa-Leiker, Mary Rose Mamey, et al.
Journal of Substance Abuse Treatment|February 26, 2013
Criminal justice referral and incentives in outpatient substance abuse treatmentAnthony DeFulio, Maxine Stitzer, John Roll, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 7, 2025
Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative AnalysisCrystal Lederhos Smith, Nathan Sackett, Brian Connor Stark, et al.
Behavioural Pharmacology|June 10, 2020
Crossover associations of alcohol and smoking, craving and biochemically verified alcohol and nicotine use in heavy drinking smokersCrystal Lederhos Smith, Garrett Jenkins, Ekaterina Burduli, et al.
Substance Abuse|January 31, 2022
Youth risk profiles and their prediction of distal cannabis and tobacco co-use in the Population Assessment of Tobacco Health (PATH)Crystal Lederhos Smith, Brittany Rhoades Cooper, Andre Miguel, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Journal of Opioid Management|April 7, 2012
Buprenorphine therapy for opioid addiction in rural Washington: the experience of the early adoptersTyler L Quest, Joseph O Merrill, John Roll, et al.
Journal of Cannabis Research|June 2, 2021
Predictors of cannabis and tobacco co-use in youth: exploring the mediating role of age at first use in the population assessment of tobacco health (PATH) studyCrystal Lederhos Smith, Brittany Rhoades Cooper, Andre Miguel, et al.
Behavioural Pharmacology|February 18, 2016
Self-reported smoking effects and comparative value between cigarettes and high dose e-cigarettes in nicotine-dependent cigarette smokersSterling McPherson, Donelle Howell, Jennifer Lewis, et al.
Rural and Remote Health|March 23, 2017
Use of cell phones and computers for health promotion and tobacco cessation by American Indian college students in MontanaJo Ann W Dotson, Lonnie A Nelson, Sara L Young, et al.
Experimental and Clinical Psychopharmacology|September 22, 2015
An application of analyzing the trajectories of two disorders: A parallel piecewise growth model of substance use and attention-deficit/hyperactivity disorderMary Rose Mamey, Celestina Barbosa-Leiker, Sterling McPherson, et al.
Addiction (Abingdon, England)|August 30, 2014
A 'missing not at random' (MNAR) and 'missing at random' (MAR) growth model comparison with a buprenorphine/naloxone clinical trialSterling McPherson, Celestina Barbosa-Leiker, Mary Rose Mamey, et al.
Journal of Substance Abuse Treatment|February 26, 2013
Criminal justice referral and incentives in outpatient substance abuse treatmentAnthony DeFulio, Maxine Stitzer, John Roll, et al.
Psychedelic Medicine (New Rochelle, N.Y.)|March 7, 2025
Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative AnalysisCrystal Lederhos Smith, Nathan Sackett, Brian Connor Stark, et al.
Behavioural Pharmacology|June 10, 2020
Crossover associations of alcohol and smoking, craving and biochemically verified alcohol and nicotine use in heavy drinking smokersCrystal Lederhos Smith, Garrett Jenkins, Ekaterina Burduli, et al.
Substance Abuse|January 31, 2022
Youth risk profiles and their prediction of distal cannabis and tobacco co-use in the Population Assessment of Tobacco Health (PATH)Crystal Lederhos Smith, Brittany Rhoades Cooper, Andre Miguel, et al.
Pageof 7